Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients – a network meta-analysis
Patients with benign prostatic hyperplasia (BPH) receive α-blockers as first-line therapy to treat lower urinary tract symptoms; however, some individuals still experience residual storage symptoms. Antimuscar...
Source: BMC Urology - Category: Urology & Nephrology Authors: Yi-Ting Su, Hsiao-Ling Chen, Jeremy Yuen-Chun Teoh, Vinson Wai-Shun Chan, Wen-Jeng Wu and Hsiang-Ying Lee Tags: Research Source Type: research
More News: Benign Prostatic Hyperplasia | Urology & Nephrology